Biopharmaceuticals are drugs having a biological origin. These large and complex drugs, which often comprise heterogeneous mixtures, are produced using biotechnology and usually from genetically engineered cells. The global biopharmaceuticals market accounted for $186,470 million in 2017, and is projected to reach $526,008 million by 2025, registering a CAGR of 13.8% from 2018 to 2025.
Major Key Players of the Biopharmaceuticals Market are:
Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer, Inc., Sanofi
No comments:
Post a Comment